News
September 2014
Apex Pharmaceuticals Inc. appoints Dr. Prem Nandiwada M.D. as a member of the Board of Directors. Dr. Nandiwada is a gastroenterologist in Old Bridge, NJ and is affiliate with multiple areas hospitals, with over 25 years in practice.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
August 2014
Apex Pharmaceuticals Inc. initiates expansion of additional suites to accommodate commercial manufacturing.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
July 2014
Apex Pharmaceuticals Inc. achieved successful pivotal bio study for a modify release formulation.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
June 2014
Apex Pharmaceuticals Inc. developed, manufactured and filed two additional ANDA with the US FDA of a project developed with a partner.
 
   
May 2014
Apex Pharmaceuticals Inc. developed, manufactured and filed an ANDA with the US FDA.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
April 2014
Apex Pharmaceuticals Inc. announces successful pilot bio study for a modify release formulation.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
March 2014
Apex Pharmaceuticals Inc. announces successful pivotal bio study for a BCS Class IV drug product.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
November 2013
Apex Pharmaceuticals Inc. announces pilot bio studies successfully completed for a BCS Class IV drug product.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
August 2012
Apex Pharmaceuticals, Inc. upgrades its facility to accommodate pilot scale manufacturing under cGMP conditions.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------  
November 2011
Apex Pharmaceuticals Inc. announces first ANDA filing accepted by the US FDA for a drug product. Developed with a partner.
 
---------------------------------------------------------------------------------------------------------------------------------------------------------